These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24293470)

  • 1. Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
    Guignabert C; Tu L; Le Hiress M; Ricard N; Sattler C; Seferian A; Huertas A; Humbert M; Montani D
    Eur Respir Rev; 2013 Dec; 22(130):543-51. PubMed ID: 24293470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New horizons in pulmonary arterial hypertension therapies.
    Galiè N; Ghofrani AH
    Eur Respir Rev; 2013 Dec; 22(130):503-14. PubMed ID: 24293466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from oncology to understand and treat pulmonary hypertension.
    Adnot S; Eddahibi S
    Int J Clin Pract Suppl; 2007 Dec; (158):19-25. PubMed ID: 18078390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?].
    Dumas SJ; Humbert M; Cohen-Kaminsky S
    Biol Aujourdhui; 2016; 210(4):171-189. PubMed ID: 28327277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pulmonary arterial hypertension with targeted therapies.
    O'Callaghan DS; Savale L; Montani D; Jaïs X; Sitbon O; Simonneau G; Humbert M
    Nat Rev Cardiol; 2011 Jul; 8(9):526-38. PubMed ID: 21769113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.
    Voelkel NF; Gomez-Arroyo J
    Am J Respir Cell Mol Biol; 2014 Oct; 51(4):474-84. PubMed ID: 24932885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Looking to the future: a new decade of pulmonary arterial hypertension therapy.
    McLaughlin VV
    Eur Respir Rev; 2011 Dec; 20(122):262-9. PubMed ID: 22130819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?
    Courboulin A; Ranchoux B; Cohen-Kaminsky S; Perros F; Bonnet S
    Curr Opin Oncol; 2016 Jan; 28(1):72-82. PubMed ID: 26569423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New insights in the pathogenesis of pulmonary arterial hypertension].
    Bordenave J; Tu L; Savale L; Huertas A; Humbert M; Guignabert C
    Rev Mal Respir; 2019 Apr; 36(4):433-437. PubMed ID: 31010759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension.
    Chaumais MC; Guignabert C; Savale L; Jaïs X; Boucly A; Montani D; Simonneau G; Humbert M; Sitbon O
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):13-26. PubMed ID: 25421754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
    Boucherat O; Peterlini T; Bourgeois A; Nadeau V; Breuils-Bonnet S; Boilet-Molez S; Potus F; Meloche J; Chabot S; Lambert C; Tremblay E; Chae YC; Altieri DC; Sutendra G; Michelakis ED; Paulin R; Provencher S; Bonnet S
    Am J Respir Crit Care Med; 2018 Jul; 198(1):90-103. PubMed ID: 29394093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities.
    Sakao S; Tatsumi K
    Int J Cardiol; 2011 Feb; 147(1):4-12. PubMed ID: 20692712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative and nitrosative signalling in pulmonary arterial hypertension - Implications for development of novel therapies.
    Hansen T; Galougahi KK; Celermajer D; Rasko N; Tang O; Bubb KJ; Figtree G
    Pharmacol Ther; 2016 Sep; 165():50-62. PubMed ID: 27216365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological function of Ca2+-sensing receptor in pulmonary arterial hypertension.
    Yamamura A
    J Smooth Muscle Res; 2014; 50():8-17. PubMed ID: 24770445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.
    Goncharov DA; Kudryashova TV; Ziai H; Ihida-Stansbury K; DeLisser H; Krymskaya VP; Tuder RM; Kawut SM; Goncharova EA
    Circulation; 2014 Feb; 129(8):864-74. PubMed ID: 24270265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
    Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
    Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic theory of pulmonary arterial hypertension.
    Paulin R; Michelakis ED
    Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.
    Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR
    Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.